OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation
Hongxia Cheng, Sikai Wang, Dongmei Gao, et al.
Cellular Oncology (2022) Vol. 46, Iss. 2, pp. 283-297
Closed Access | Times Cited: 15
Hongxia Cheng, Sikai Wang, Dongmei Gao, et al.
Cellular Oncology (2022) Vol. 46, Iss. 2, pp. 283-297
Closed Access | Times Cited: 15
Showing 15 citing articles:
Novel anticancer drug discovery efforts targeting glycosylation: the emergence of fluorinated monosaccharides analogs
Ana Costa, Andreia Teixeira, Celso A. Reis, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-11
Closed Access | Times Cited: 1
Ana Costa, Andreia Teixeira, Celso A. Reis, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-11
Closed Access | Times Cited: 1
Altered glycosylation in cancer: molecular functions and therapeutic potential
Xuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Cancer Communications (2024) Vol. 44, Iss. 11, pp. 1316-1336
Open Access | Times Cited: 7
Xuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Cancer Communications (2024) Vol. 44, Iss. 11, pp. 1316-1336
Open Access | Times Cited: 7
Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2
Shengshan Xu, Xiguang Chen, Jianxiong Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Shengshan Xu, Xiguang Chen, Jianxiong Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
SLC35A2 is a novel prognostic biomarker and promotes cell proliferation and metastasis via Wnt/β-catenin/EMT signaling pathway in breast cancer
Rushu Yan, Tianwen Chen
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Rushu Yan, Tianwen Chen
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
SLC35A2 modulates paramyxovirus fusion events during infection
Yanling Yang, Yuchen Wang, Danielle E. Campbell, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012531-e1012531
Open Access
Yanling Yang, Yuchen Wang, Danielle E. Campbell, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012531-e1012531
Open Access
Higher order synthetic lethals are keys to minimize cancer treatment effects on non-tumor cells
Mehdi Dehghan Manshadi, Payam Setoodeh, Amin Ramezani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Mehdi Dehghan Manshadi, Payam Setoodeh, Amin Ramezani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
SLC35A2-mediated bisected GlcNAc-modified extracellular vesicles enhance immune regulation in breast cancer lung metastasis
Yangyang Li, Tao Guo, Juntong He, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114505-114505
Closed Access
Yangyang Li, Tao Guo, Juntong He, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114505-114505
Closed Access
Clinical glycoproteomics: methods and diseases
Yujia Wang, Kaixin Lei, Lijun Zhao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 3
Yujia Wang, Kaixin Lei, Lijun Zhao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 3
Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mTOR axis, promoting the proliferation, migration, and invasion of osteosarcoma cells
Xiaohui Luo, Jiongfeng Zhang, Chong Guo, et al.
Gene (2023) Vol. 898, pp. 148110-148110
Closed Access | Times Cited: 6
Xiaohui Luo, Jiongfeng Zhang, Chong Guo, et al.
Gene (2023) Vol. 898, pp. 148110-148110
Closed Access | Times Cited: 6
Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer
Xiaonan Sun, Zhichao Yuan, Lu Zhang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 3381-3398
Open Access | Times Cited: 5
Xiaonan Sun, Zhichao Yuan, Lu Zhang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 3381-3398
Open Access | Times Cited: 5
Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications
Yu Zhang, Weihao Xu, Chuanhui Peng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Yu Zhang, Weihao Xu, Chuanhui Peng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
MicroRNA PC-3p-2869 Regulates Antler Growth and Inhibits Proliferation and Migration of Human Osteosarcoma and Chondrosarcoma Cells by Targeting CDK8, EEF1A1, and NTN1
Fan Yang, Jin Wu, Mindie Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10840-10840
Open Access | Times Cited: 3
Fan Yang, Jin Wu, Mindie Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10840-10840
Open Access | Times Cited: 3
Comprehensive analysis of transcriptome data and experimental identification show that solute carrier 35 member A2 (SLC35A2) is a prognostic marker of colorectal cancer
Yue Wang, Liang Chen, Jing Chen, et al.
Aging (2023)
Open Access | Times Cited: 3
Yue Wang, Liang Chen, Jing Chen, et al.
Aging (2023)
Open Access | Times Cited: 3
Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma
Qingzhu Zheng, Mingjie Li, Ying‐Kun Qiu, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23828-e23828
Open Access | Times Cited: 1
Qingzhu Zheng, Mingjie Li, Ying‐Kun Qiu, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23828-e23828
Open Access | Times Cited: 1
Xinyue Wang, Ya Lu, Yuan Zhang, et al.
Precision Medical Sciences (2023) Vol. 12, Iss. 2, pp. 121-129
Open Access
